← Back to All US Stocks

CAH Stock Analysis - CARDINAL HEALTH INC AI Rating

CAH NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries OH CIK: 0000721371
Recently Updated • Analysis: Mar 21, 2026 • SEC Data: 2025-12-31
AI Rating
SELL
75% Confidence

📊 CAH Key Takeaways

Revenue: $129.6B
Net Margin: 0.7%
Free Cash Flow: $1.4B
Current Ratio: 0.91x
Debt/Equity: N/A
EPS: $1.88
AI Rating: SELL with 75% confidence

Investment Thesis

Cardinal Health exhibits concerning financial deterioration with negative stockholders' equity of $2.9B, indicating the company is technically insolvent from an equity perspective. Despite maintaining reasonable operational cash flow of $1.7B, the combination of razor-thin margins (0.7% net margin), declining revenue (-1.9% YoY), and severely strained liquidity ratios (0.91x current ratio) suggests structural operational challenges in the wholesale drug distribution sector. The negative equity position raises substantial questions about long-term sustainability and financial flexibility.

CAH Strengths

  • + Positive operating cash flow of $1.7B demonstrates ability to generate cash from operations
  • + Solid free cash flow of $1.4B after capex provides some financial cushion for debt service
  • + Interest coverage ratio of 8.2x indicates current debt obligations are manageable from an operational standpoint
  • + Maintains $2.8B in cash reserves providing short-term liquidity buffer

CAH Risks

  • ! Negative stockholders' equity of -$2.9B signals the company is technically insolvent and equity investors have negative book value
  • ! Liquidity crisis indicators: current ratio of 0.91x and quick ratio of 0.44x both below safe thresholds, suggesting potential working capital stress
  • ! Revenue declining 1.9% YoY with extremely thin net margins of 0.7%, leaving minimal operational flexibility or cushion for disruptions
  • ! High long-term debt of $8.3B relative to equity base creates refinancing risk and limits financial flexibility
  • ! Structural profitability challenges with gross margin of only 3.6% in a capital-intensive wholesale distribution business

Key Metrics to Watch

CAH Financial Metrics

Revenue
$129.6B
Net Income
$917.0M
EPS (Diluted)
$1.88
Free Cash Flow
$1.4B
Total Assets
$58.1B
Cash Position
$2.8B

💡 AI Analyst Insight

The relatively thin 1.1% FCF margin may limit capital allocation flexibility. The current ratio below 1.0x warrants monitoring of short-term liquidity.

CAH Profitability Ratios

Gross Margin 3.6%
Operating Margin 1.1%
Net Margin 0.7%
ROE N/A
ROA 1.6%
FCF Margin 1.1%

CAH vs Default Sector

How CARDINAL HEALTH INC compares to Default sector averages

Net Margin
CAH 0.7%
vs
Sector Avg 12.0%
CAH Sector
ROE
CAH 0.0%
vs
Sector Avg 15.0%
CAH Sector
Current Ratio
CAH 0.9x
vs
Sector Avg 1.8x
CAH Sector
Debt/Equity
CAH 0.0x
vs
Sector Avg 0.7x
CAH Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CAH Balance Sheet & Liquidity

Current Ratio
0.91x
Quick Ratio
0.44x
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
8.18x
Long-term Debt
$8.3B

CAH 5-Year Financial Trend

CAH 5-year financial data: Year 2021: Revenue $162.5B, Net Income $1.4B, EPS $4.53. Year 2022: Revenue $181.4B, Net Income -$3.7B, EPS $-12.61. Year 2023: Revenue $205.0B, Net Income $611.0M, EPS $2.08. Year 2024: Revenue $226.8B, Net Income -$938.0M, EPS $-3.37. Year 2025: Revenue $226.8B, Net Income $330.0M, EPS $1.26.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: CARDINAL HEALTH INC's revenue has grown significantly by 40% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.26 reflects profitable operations.

CAH Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
1.1%
Free cash flow / Revenue

CAH Quarterly Performance

Quarterly financial performance data for CARDINAL HEALTH INC including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q2 2026 $55.3B $400.0M N/A
Q1 2026 $52.3B $416.0M $1.70
Q3 2025 $54.9B $261.0M N/A
Q2 2025 $55.3B $356.0M N/A
Q1 2025 $52.3B -$12.0M $-0.05
Q3 2024 $50.5B $258.0M N/A
Q2 2024 $51.5B -$20.0M N/A
Q1 2024 $49.6B $5.0M $0.02

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

CAH Capital Allocation

Operating Cash Flow
$1.7B
Cash generated from operations
Stock Buybacks
$758.0M
Shares repurchased (TTM)
Capital Expenditures
$239.0M
Investment in assets
Dividends Paid
$251.0M
Returned to shareholders

CAH SEC Filings

Access official SEC EDGAR filings for CARDINAL HEALTH INC (CIK: 0000721371)

📋 Recent SEC Filings

Date Form Document Action
Mar 5, 2026 8-K cah-20260302.htm View →
Mar 3, 2026 4 xslF345X05/wk-form4_1772572274.xml View →
Feb 18, 2026 4 xslF345X05/wk-form4_1771449933.xml View →
Feb 10, 2026 4 xslF345X05/wk-form4_1770757977.xml View →
Feb 5, 2026 10-Q cah-20251231.htm View →

Frequently Asked Questions about CAH

What is the AI rating for CAH?

CARDINAL HEALTH INC (CAH) has an AI rating of SELL with 75% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CAH's key strengths?

Positive operating cash flow of $1.7B demonstrates ability to generate cash from operations. Solid free cash flow of $1.4B after capex provides some financial cushion for debt service.

What are the risks of investing in CAH?

Negative stockholders' equity of -$2.9B signals the company is technically insolvent and equity investors have negative book value. Liquidity crisis indicators: current ratio of 0.91x and quick ratio of 0.44x both below safe thresholds, suggesting potential working capital stress.

What is CAH's revenue and growth?

CARDINAL HEALTH INC reported revenue of $129.6B.

Does CAH pay dividends?

CARDINAL HEALTH INC pays dividends, with $251.0M distributed to shareholders in the trailing twelve months.

Where can I find CAH SEC filings?

Official SEC filings for CARDINAL HEALTH INC (CIK: 0000721371) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CAH's EPS?

CARDINAL HEALTH INC has a diluted EPS of $1.88.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 21, 2026 | Data as of: 2025-12-31 | Powered by Claude AI